Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.
Press releases published on May 9, 2025
Veteran Innovator Unites AI, Trauma, Spirituality, and Sustainability
EIN Presswire
·
May 9, 2025
SACRAMENTO, CA, UNITED STATES, May 10, 2025 /EINPresswire.com/ -- In a powerful and deeply personal conversation hosted by Xraised, Marcus Banks-Bey—Founder and CEO of Life Ambassadors International—shares his transformative journey from a 20-year U.S. …
A groundbreaking discovery of a common master switch to cure Alzheimer’s, Parkinson’s, and other brain-related diseases
EIN Presswire
·
May 9, 2025
A breakthrough that could save millions of lives LOS ANGELES, CA, UNITED STATES, May 9, 2025 /EINPresswire.com/ -- The 21st edition of Sustainability Through Science and Technology Summit 2025 (SIPS 2025), dedicated to Prof. Aaron Ciechanover, Nobel …
WorkSpan Reports Record Quarter, Accelerates Growth with WorkSpan AI Launch
EIN Presswire
·
May 9, 2025
AI partner intelligence solution drives unprecedented new business revenue and board of directors' expansion amid growing demand for ecosystem orchestration REDWOOD CITY, CA, UNITED STATES, May 9, 2025 /EINPresswire.com/ -- WorkSpan, the industry leader …
Dr. Sam Sammane Becomes a Two-Time Bestseller with ‘Republic of Mars’
EIN Presswire
·
May 9, 2025
Dr. Sam Sammane becomes a two-time Amazon bestseller as 'Republic of Mars' joins 'The Singularity of Hope' in topping charts across categories. ANAHEIM, CA, UNITED STATES, May 9, 2025 /EINPresswire.com/ -- Dr. Sam Sammane, author, systems architect, and …
AngelHack Unveils New Brand Identity to Empower the Next Generation of Developers Worldwide
EIN Presswire
·
May 9, 2025
AngelHack doubles down on its mission to foster global innovation, launching the AngelHack Alliance to unite and support developer communities across the globe. SAN FRANCISCO, CA, UNITED STATES, May 9, 2025 /EINPresswire.com/ -- AngelHack, the global …
Historic Cali Crypto Tour Closes in Sacramento with Lawmakers, Builders & Policy Powerhouses United for Crypto Progress
EIN Presswire
·
May 9, 2025
Stand With Crypto and DIFA took over the Capitol—uniting crypto leaders and lawmakers to protect innovation and build a safer digital future. SACRAMENTO, CA, UNITED STATES, May 9, 2025 /EINPresswire.com/ -- The historic California Crypto Tour concluded …
Anonemis Research & Simenona Martinez Unveil Tech Breakthrough to Transform Media & Transportation Markets
EIN Presswire
·
May 9, 2025
SAN FRANCISCO, CA, UNITED STATES, May 9, 2025 /EINPresswire.com/ -- Anonemis Research, LLC and inventor Simenona Martinez have introduced two new technologies: the AR Quantum Apparatus for entertainment applications and the Digital Licensing and GPS- …
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
GlobeNewswire
·
May 9, 2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today announced that it will present full 12 …
Orezone Gold Reports Fatality at Stage I Hard Rock Plant Construction Site
GlobeNewswire
·
May 9, 2025
VANCOUVER, British Columbia, May 09, 2025 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (“Orezone”) regrets to report a fatality at the Stage I hard rock plant construction site at its Bomboré Gold Mine which occurred on Thursday …
Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting
GlobeNewswire
·
May 9, 2025
First Oral Presentation by the International Guillain-Barré Syndrome Outcomes Study (IGOS) of the Real-World Evidence (RWE) Results Showing Improved Outcomes with Tanruprubart (formerly ANX005) Compared to Current Standards of Care in Matched Patient …
Theriva Biologics anuncia el cierre de una oferta pública de 7,5 millones de dólares
GlobeNewswire
·
May 9, 2025
ROCKVILLE, Maryland, May 09, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), («Theriva» o la «empresa»), una empresa diversificada en fase clínica que desarrolla terapias diseñadas para tratar el cáncer y enfermedades relacionadas en …
Coave Therapeutics Launches coAAV-CSF-01, a Novel CNS-Targeted Gene Therapy Vector for Neurodegenerative and other CNS Diseases
GlobeNewswire
·
May 9, 2025
New breakthrough data from studies with Coave’s ALIGATER™-engineered AAV2-based capsid coAAV-CSF-01 (S01coAAV2) demonstrates improved brain tissue transduction and safety following intra-cerebrospinal fluid administration in non-human primates Data …
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 9, 2025
CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today …
BioCardia to Host Q1 2025 Corporate Update and Financial Results Conference Call on May 14, 2025
GlobeNewswire
·
May 9, 2025
SUNNYVALE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and …
Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 9, 2025
SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway for tissue repair and regeneration …
Oculis Publishes Invitation to the Annual General Meeting
GlobeNewswire
·
May 9, 2025
ZUG, Switzerland, May 09, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), today published the invitation to the 2025 Annual General Meeting, which will be held on June 4, 2025 at Ochsen-Zug, Kolinplatz 11, CH-6300 Zug, …
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 9, 2025
MALVERN, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee …
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 9, 2025
PRINCETON, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …
Entera Bio Announces First Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
May 9, 2025
JERUSALEM, May 09, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key business updates for the quarter ended March 31, 2025. “ …
Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates
GlobeNewswire
·
May 9, 2025
Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS); full healthy volunteer data expected in 2H25 On-track to enable dosing ALS patients in late 2025 BOTHELL, Wash., May 09, 2025 ( …